MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.

MLA

Clegg, Nicola J., et al. “MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to MTOR Inhibitors.” PloS One, vol. 6, no. 3, Mar. 2011, p. e17449. EBSCOhost, https://doi.org/10.1371/journal.pone.0017449.

APA

Clegg, N. J., Couto, S. S., Wongvipat, J., Hieronymus, H., Carver, B. S., Taylor, B. S., Ellwood-Yen, K., Gerald, W. L., Sander, C., & Sawyers, C. L. (2011). MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors. PloS One, 6(3), e17449. https://doi.org/10.1371/journal.pone.0017449

Chicago

Clegg, Nicola J, Suzana S Couto, John Wongvipat, Haley Hieronymus, Brett S Carver, Barry S Taylor, Katharine Ellwood-Yen, William L Gerald, Chris Sander, and Charles L Sawyers. 2011. “MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to MTOR Inhibitors.” PloS One 6 (3): e17449. doi:10.1371/journal.pone.0017449.